|
Isuzinaxib (APX-115) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Isuzinaxib Hydrochloride
Dallas, Texas1 trial
Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
Baylor Scott & White Research Institute
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.